MX2010014441A - Diaril ureas para tratar la insuficiencia cardiaca. - Google Patents
Diaril ureas para tratar la insuficiencia cardiaca.Info
- Publication number
- MX2010014441A MX2010014441A MX2010014441A MX2010014441A MX2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A MX 2010014441 A MX2010014441 A MX 2010014441A
- Authority
- MX
- Mexico
- Prior art keywords
- heart failure
- treating heart
- diaryl ureas
- diaryl
- urea compound
- Prior art date
Links
- -1 Diaryl ureas Chemical class 0.000 title abstract 3
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 235000013877 carbamide Nutrition 0.000 title 1
- 239000004202 carbamide Substances 0.000 abstract 2
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960003787 sorafenib Drugs 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08011471 | 2008-06-25 | ||
| PCT/EP2009/004390 WO2009156089A1 (en) | 2008-06-25 | 2009-06-18 | Diaryl ureas for treating heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010014441A true MX2010014441A (es) | 2011-01-21 |
Family
ID=41136709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010014441A MX2010014441A (es) | 2008-06-25 | 2009-06-18 | Diaril ureas para tratar la insuficiencia cardiaca. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110263657A1 (enExample) |
| EP (1) | EP2293792A1 (enExample) |
| JP (1) | JP2011525506A (enExample) |
| KR (1) | KR20110031294A (enExample) |
| CN (1) | CN102076338A (enExample) |
| AU (1) | AU2009262599A1 (enExample) |
| BR (1) | BRPI0914636A2 (enExample) |
| CA (1) | CA2729050A1 (enExample) |
| IL (1) | IL209647A0 (enExample) |
| MX (1) | MX2010014441A (enExample) |
| RU (1) | RU2011102471A (enExample) |
| WO (1) | WO2009156089A1 (enExample) |
| ZA (1) | ZA201009063B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102718703B (zh) * | 2011-03-31 | 2016-09-14 | 中国医学科学院药物研究所 | Gk和ppar双重激动活性的含有二甲基的芳基脲类衍生物 |
| EP2723718A1 (en) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| AP2013007331A0 (en) | 2011-06-24 | 2013-12-31 | Amgen Inc | TRPM8 antagonists and their use in treatments |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| RU2646454C2 (ru) * | 2013-11-12 | 2018-03-05 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" | Способ моделирования алкогольной кардиомиопатии |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1636585B2 (en) * | 2003-05-20 | 2012-06-13 | Bayer HealthCare LLC | Diaryl ureas with kinase inhibiting activity |
| PL1663978T3 (pl) * | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| WO2007087575A2 (en) * | 2006-01-24 | 2007-08-02 | University Of Chicago | Compositions and methods for treating pulmonary hypertension |
| WO2009092442A1 (en) * | 2008-01-23 | 2009-07-30 | Universidad De Barcelona | Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways |
-
2009
- 2009-06-18 CN CN2009801240616A patent/CN102076338A/zh active Pending
- 2009-06-18 CA CA2729050A patent/CA2729050A1/en not_active Abandoned
- 2009-06-18 US US13/001,145 patent/US20110263657A1/en not_active Abandoned
- 2009-06-18 MX MX2010014441A patent/MX2010014441A/es not_active Application Discontinuation
- 2009-06-18 WO PCT/EP2009/004390 patent/WO2009156089A1/en not_active Ceased
- 2009-06-18 KR KR1020107029143A patent/KR20110031294A/ko not_active Withdrawn
- 2009-06-18 BR BRPI0914636A patent/BRPI0914636A2/pt not_active IP Right Cessation
- 2009-06-18 JP JP2011515168A patent/JP2011525506A/ja not_active Withdrawn
- 2009-06-18 AU AU2009262599A patent/AU2009262599A1/en not_active Abandoned
- 2009-06-18 EP EP09768938A patent/EP2293792A1/en not_active Withdrawn
- 2009-06-18 RU RU2011102471/15A patent/RU2011102471A/ru not_active Application Discontinuation
-
2010
- 2010-11-30 IL IL209647A patent/IL209647A0/en unknown
- 2010-12-17 ZA ZA2010/09063A patent/ZA201009063B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009262599A1 (en) | 2009-12-30 |
| IL209647A0 (en) | 2011-02-28 |
| JP2011525506A (ja) | 2011-09-22 |
| KR20110031294A (ko) | 2011-03-25 |
| BRPI0914636A2 (pt) | 2015-10-20 |
| ZA201009063B (en) | 2012-02-29 |
| US20110263657A1 (en) | 2011-10-27 |
| CN102076338A (zh) | 2011-05-25 |
| CA2729050A1 (en) | 2009-12-30 |
| EP2293792A1 (en) | 2011-03-16 |
| WO2009156089A1 (en) | 2009-12-30 |
| RU2011102471A (ru) | 2012-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088429A (es) | Diarilureas para el tratamiento de la hipertensión pulmonar | |
| WO2011041729A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| WO2011017350A3 (en) | Compounds as lysophosphatidic acid receptor antagonists | |
| EA200901442A1 (ru) | Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах | |
| EP2377849A4 (en) | CHEMICAL INHIBITOR OF THE P53 SNAIL BINDING AND PHARMACEUTICAL COMPOSITION FOR TUMOR TREATMENT WITH THE INHIBITOR AS AN ACTIVE SUBSTANCE | |
| WO2012078593A3 (en) | Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis | |
| TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
| PL2134704T3 (pl) | Związki i kompozycje pełniące rolę modulatorów aktywności GPR119 | |
| WO2010077883A3 (en) | Antagonists of lysophosphatidic acid receptors | |
| UA98839C2 (en) | N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors | |
| IN2012DN02702A (enExample) | ||
| WO2011163648A8 (en) | Cns delivery of therapeutic agents | |
| PH12013500919B1 (en) | Vasoprotective and cardioprotective antidiabetic therapy | |
| EP2512479A4 (en) | METHOD AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | |
| WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
| TNSN08140A1 (enExample) | ||
| TW200745124A (en) | Azepinoindole derivatives as pharmaceutical agents | |
| BR112014015568A2 (pt) | compostos carbamato de fenila para uso em prevenção ou tratamento de epilepsia | |
| AR047993A1 (es) | Composicion farmaceutica que comprende pimobendano | |
| MX2007014920A (es) | Politerapia que comprende diarilureas para el tratamiento de enfermedades. | |
| WO2008048648A3 (en) | Cb1-modulating compounds and their use | |
| WO2010062506A3 (en) | Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors | |
| WO2009158007A3 (en) | Methods and compositions for therapeutic treatment | |
| MA32416B1 (fr) | 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation | |
| WO2008103916A3 (en) | Compositions and methods for treating cancer or a neurotrophic disorder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |